Total RA Patients | RA Patients Efficacy/failures | RA Patients Toxicity/Unmet needs | |
Etanercept (Anti-TNF) | 50 | All achieved LDA (ACR 50 DAS 28 < 3.2* (last assessment) Relapse rates uncertain** | 1 patient-pulm. TB2 patients-UTI2 patients-folliculitis and abscess 1 patient-lower limb vasculitis (palpable purpura) 1 patient-H. Zoster |
Infliximab (Anti-TNF) | 27 | All achieved LDA (ACR 50 DAS 28 < 3.2* (last assessment) Relapse rates uncertain** | 2 patients-broncho-pneumonia1 patient-UTI1 patient-cellulitis |